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Introduction
Tight association of the pro-inflammatory events with
the pathogenesis of a majority of serious human diseases
(neoplasia, neurodegenetarions, cardiovascular and
others) in addition to inflammatory and autoinflamma-
tory diseases is firmly documented. S100A4 is a metasta-
sis-promoting gene whose expression has been found
implicated in chronic inflammation. Earlier we have
shown an immense upregulation of S100A4 in affected
tissues and plasma of patients suffering from rheumatoid
arthritis, psoriasis, dermato/polymyositis 1 - 3, as well as
in pro-inflammarory pathways in tumor metastasis 4,5.
However, its role in inflammation remains unclear.
Objectives
Objectives of the work were (1) to further explore the
involvement of S100A4 in chronic inflammatory disor-
ders in humans and (2) disclose the molecular mechan-
isms implicating S100A4 in the pathogenesis of
inflammation- associated, particularly in cancer progres-
sion (metastasis).
Methods
We have used several approaches to explore the role of
S100A4 in proinflammatory pathways stimulatimg can-
cer progression. These include in vitro (q-RT-PCR,
Sandwich ELISA and others) , as well as in vivo mouse
models for validation of the significance of pro-inflam-
matory factors in tumor metastasis
Results
We have obtained data demonstrating a significant
increase of S100A4 in plasma of patients with Familial
Mediterranean Fever (FMF) likely implicating implica-
tion of S100A4 in the pathogenesis of the disease.
Correlation of the S100A4 concentration in plasma with
a pattern of the genetic point mutations in MEFV gene
has been analyzed.
Here we will also present data elucidating a putative
link of S100A4 with inflammation on the model of
cancer progression. We found that the acute phase
response proteins Serum Amyloid A (SAA) 1 and
SAA3 are transcriptional targets of S100A4 via TLR4/
NF-B signaling. Data obtained demonstrated SAA
proteins stimulate their own transcription, as well as
that of S100A8, S100A9, RANTES, G-CSF, MMP2,
MMP3, MMP9 and MMP13. They strongly enhanced
tumor cell adhesion to fibronectin, and stimulated che-
motactic migration. Intravenously-injected S100A4
protein induced expression of SAA1 and SAA3 in an
organ-specific manner. In a breast cancer animal
model, ectopic expression of SAA1 or SAA3 in tumor
cells potently promoted wide spread metastasis forma-
tion accompanied by a massive infiltration of immune
cells.
Conclusion
These findings suggest that chronic inflammation
mediated by S100A4 and SAA proteins can promote
metastasis, and thus that therapeutic targeting of such
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